Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berkeley Heights, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Tonix Pharmaceuticals Holding Corp. has filed 1,504 SEC EDGAR filings since 09 Apr 2008

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page
25
Current page
21
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
28 Sep 2021
Reporting date
28 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
23 Sep 2021
Reporting date
23 Sep 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
21 Sep 2021
Reporting date
21 Sep 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
13 Sep 2021
Reporting date
13 Sep 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
07 Sep 2021
Reporting date
03 Sep 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
27 Aug 2021
Reporting date
27 Aug 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
24 Aug 2021
Reporting date
24 Aug 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
09 Aug 2021
Reporting date
09 Aug 2021
Next action
Verify source filing
10-Q File 001-36019

QUARTERLY REPORT

Filing date
09 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
27 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
27 Jul 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
23 Jul 2021
Reporting date
23 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRRENT REPORT

Filing date
19 Jul 2021
Reporting date
16 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRRENT REPORT

Filing date
28 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-257437

INITIAL REGISTRATION STATEMENT

Filing date
25 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
24 Jun 2021
Reporting date
24 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
22 Jun 2021
Reporting date
22 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
21 Jun 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
03 Jun 2021
Reporting date
03 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

GOODMAN - CHANGES IN BENEFICIAL OWNERSHIP

Filing date
26 May 2021
Reporting date
25 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .